MARINUS PHARMACEUTICALS INC (MRNS) Stock Balance Sheet
NASDAQ:MRNS - Nasdaq - US56854Q2003 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 42.18M | 120.57M | 240.60M | 122.90M | 138.50M | |||
| Marketable Securities | N/A | 29.72M | N/A | 0.00 | 1.50M | |||
| Receivables | 3.84M | 3.80M | 6.30M | 3.20M | 1.60M | |||
| Inventories | 6.72M | 2.41M | 100.00K | N/A | N/A | |||
| Other Current Assets | 4.66M | 8.75M | 5.40M | 5.60M | 4.60M | |||
| Total Current Assets | 57.40M | 165.25M | 252.40M | 131.70M | 146.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.38M | 4.84M | 5.50M | 4.20M | 3.90M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 841.00K | 819.00K | 1.60M | 1.00M | 300.00K | |||
| Total Non-Current Assets | 6.22M | 5.66M | 7.10M | 5.10M | 4.20M | |||
| TOTAL ASSETS | 63.62M | 170.91M | 259.50M | 136.80M | 150.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 13.47M | 11.55M | N/A | N/A | N/A | |||
| Accrued Expenses | 14.16M | 22.86M | 19.50M | 16.20M | 8.50M | |||
| Accounts Payable | 3.71M | 4.00M | 4.50M | 3.10M | 2.20M | |||
| Other Current Liabilities | 3.16M | 2.21M | 1.00M | 21.20M | N/A | |||
| Total Current Liabilities | 34.50M | 40.62M | 25.00M | 40.60M | 10.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 41.71M | 61.42M | 71.00M | 40.80M | 0.00 | |||
| Other Non-Current Liabilities | 54.15M | 52.10M | 47.50M | 2.00M | 2.50M | |||
| Total Non-Current Liabilities | 95.86M | 113.52M | 118.50M | 42.80M | 2.60M | |||
| TOTAL LIABILITIES | 130.36M | 154.14M | 143.50M | 83.40M | 13.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -670.65M | -571.93M | -430.50M | -410.70M | -311.90M | |||
| Additional Paid In Capital | 603.85M | 588.66M | 542.40M | 459.90M | 444.60M | |||
| Common Shares | 55.00K | 55.00K | 4.10M | 4.30M | 4.50M | |||
| Treasury Stock | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | -20.00K | N/A | 53.49M | N/A | |||
| Shares Outstanding | 55.19M | 54.58M | 49.60M | 36.80M | 36.60M | |||
| Tangible Book Value per Share | -1.21 | 0.31 | 2.26 | 1.34 | 3.63 | |||
| Total Shareholders' Equity | -66.74M | 16.77M | 116.00M | 53.50M | 137.20M | |||
| TOTAL LIABILITIES AND EQUITY | 63.62M | 170.91M | 259.50M | 136.80M | 150.50M | |||
| Statistics | ||||||||
| Debt/Equity | -0.63 | 3.66 | 0.61 | 0.76 | N/A | |||
| Current Ratio | 1.66 | 4.07 | 10.10 | 3.24 | 13.67 | |||
| Return On Assets (ROA) | -220.81% | -82.74% | -7.64% | -72.21% | -50.74% | |||
| Return On Equity (ROE) | N/A | -843.45% | -17.09% | -184.64% | -55.66% | |||
All data in USD , ROIC based on taxRate of 0.21